 European Stroke Prevention Study ESPS results arterial distribution European Stroke Prevention Study multicenter study effect combination dipyridamole mg acetylsalicylic acid mg times day placebo patients secondary prevention stroke death transient ischemic attacks reversible ischemic neurological deficits strokes atherothrombotic origin patients vertebrobasilar events entry one-third whole patient population overall total incidence stroke death end points follow-up placebo group vertebrobasilar group carotid group combination therapy dipyridamole acetylsalicylic acid marked reduction incidence stroke death patients vertebrobasilar carotid events stroke end point dipyridamole acetylsalicylic acid effective risk transient ischemic attacks stroke effective men women